Unique ID issued by UMIN | UMIN000035870 |
---|---|
Receipt number | R000040861 |
Scientific Title | Randomized Phase II study of TJ-25 and TJ-61 in Oketsu patients with lower abdominal pain |
Date of disclosure of the study information | 2019/10/01 |
Last modified on | 2022/08/16 12:00:10 |
Randomized Phase II study of TJ-25 and TJ-61 in Oketsu patients with lower abdominal pain
Randomized Phase II study of TJ-25 and TJ-61 in Oketsu patients with lower abdominal pain
Randomized Phase II study of TJ-25 and TJ-61 in Oketsu patients with lower abdominal pain
Randomized Phase II study of TJ-25 and TJ-61 in Oketsu patients with lower abdominal pain
Japan |
Oketsu with lower abdominal pain
Obstetrics and Gynecology |
Others
YES
The purpose of this study is to evaluate therapeutic efficacy of TJ-25 or TJ-61 for Oketsu women who complain of lower abdominal pain, so that these medicines for lower abdominal pain and Oketsu symptoms.
Safety,Efficacy
Confirmatory
Explanatory
Phase II
Abdominal pain (VAS scale, dysmenorrhea score)
Oketsu seriousness (Oketsu score)
For the above, compare scores before treatment and after 28 days
Cold (cold score)
Stiff shoulder (VAS scale)
For the above, compare scores before treatment and after 28 days
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
3
Treatment
Medicine |
No additional medicine
TJ-25
TJ-61
20 | years-old | <= |
Not applicable |
Female
1) Patients who have lower abdominal pain in chief complaint and who are recommended for medication by general examination (internal examination, ultrasonic examination)
2) Patients with ECOG-PS 0 or 1
3) Patients whose main organ function is adequately maintained
(A) White blood cell count > 3,500 / mm 3, < 12 000 / mm 3
(B) Number of neutrophils > 1,500 / mm 3
(C) Platelet count > 100,000 / mm 3
(D) Hb > 9.0 g / dL
(E) AST , ALT < 100 IU / L
(F) Creatinine < 1.2 mg / dL
1) Patients with allergies to traditional Chinese medicine
2) Patients with severe complications (such as heart failure, renal failure, liver failure, hypoactive nutrition) and severe mental illness
3) Patients whose oral ingestion is impossible
4) Patients already receiving prescription of traditional Chinese medicine for the current pain episode
5) In addition, patients judged unsuitable for doctors to safely carry out this study
50
1st name | Hiroaki |
Middle name | |
Last name | Kajiyama |
Nagoya University School of Medicine
Department of obstetrics and gynecology
4668550
Tsuruma-cho 65, Showa-ku, Nagoya
052-744-2261
kajiyama@med.nagoya-u.ac.jp
1st name | Nobuhisa |
Middle name | |
Last name | Yoshikawa |
Nagoya University School of Medicine
Department of obstetrics and gynecology
4668550
Tsuruma-cho 65, Showa-ku, Nagoya
052-744-2261
n-yoshikawa@med.nagoya-u.ac.jp
Nagoya University
Japan Agency for medical research and development
Japanese Governmental office
IRB
Tsuruma-cho 65, Showa-ku, Nagoya
052-744-2423
iga-shinsa@adm.nagoya-u.ac.jp
NO
2019 | Year | 10 | Month | 01 | Day |
Unpublished
Terminated
2019 | Year | 02 | Month | 13 | Day |
2019 | Year | 02 | Month | 13 | Day |
2019 | Year | 10 | Month | 01 | Day |
2019 | Year | 10 | Month | 01 | Day |
2019 | Year | 02 | Month | 13 | Day |
2022 | Year | 08 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040861